NAFLD是指除外酒精和其他明确的损肝因素所致的肝细胞内脂肪过度沉积为主要特征的临床病理综合征,与胰岛素抵抗和遗传易感性密切相关的获得性代谢应激性肝损伤。包括单纯性脂肪肝(SFL)、非酒精性脂肪性肝炎(NASH)及其相关肝硬化。非酒精性脂肪性肝病除可直接导致失代偿期肝硬化、肝细胞癌和移植肝复发外,还可影响其他慢性...
Non-alcoholic fatty liver disease (NAFLD): summary of NICE guidance. BMJ 2016;354:i4428.Jessica, Glen,Lefteris,etc.Non-alcoholic fatty liver disease (NAFLD): summary of NICE guidance.[J].2016.Non-alcoholic fatty liver disease (NAFLD):summary of NICE guidance. Glen J,Floros L,Day C,et...
非酒精性脂肪肝(Nonalcoholic Fatty Liver Disease,NAFLD)是指酒精和其它明确的损肝因素之外所致的肝细胞内脂肪过度沉积引发的代谢应激性肝脏损伤。非酒精性脂肪性肝炎(Nonalcoholic Steatohepatitis,NASH)是NAFLD进展而来的严重慢性肝脏疾病,流行病学数据显示,15%～25%的NAFLD患者最终会发展为NASH。 全球平均每3个人中就...
Fatty Liver Disease Types There are two main types of FLD: 1. Metabolic dysfunction-associated steatotic liver disease (MASLD) This type used to be called nonalcoholic fatty liver disease (NAFLD). It is very common in the U.S., affecting 1 in 3 adults. Researchers aren't exactly sure wh...
Non-alcoholic fatty liver disease (NAFLD) is associated with low level of physical activity: a population-based study BACKGROUND: High intensity exercise improves metabolic status and may potentially mobilise hepatic fat. AIM: To assess the level of physical activity (PA) ... L Gerber,M Otgon...
非酒精性脂肪性肝病(Nonalcoholic Fatty Liver Disease,NAFLD)是一种与胰岛素抵抗和遗传易感密切相关的代谢应激性肝脏损伤,疾 病谱包括非酒精性肝脂肪变(NAFL)、非酒精性脂肪性肝炎(NASH)及NASH相关肝硬化和肝细胞癌。 NASH表现为5%以上的肝细胞脂 肪变合并小叶内炎症和肝细胞气球样变性,大约有15%~25%的NAFLD会...
There is currently no licensed treatment for NAFLD, and most people are managed by their general practitioner with a focus on lifestyle advice such as weight loss.Non-alcoholic fatty liver disease (NAFLD) is a spectrum of disease from fatty liver to non-alcoholic steatohepatitis, fibrosis, and ...
Given the increasing prevalence of diabetes and obesity worldwide, the deleterious effects of non-alcoholic fatty liver disease (NAFLD) are becoming a growing challenge for public health. NAFLD is the most common chronic liver disease in the Western world. NAFLD is closely associated with metabolic...
Nonalcoholic fatty liver disease (NAFLD) is one of the most common chronic liver disease1,2, and also an emerging risk factor for type 2 diabetes mellitus, cardiovascular disease, renal diseases and all-cause mortality3. The prevalence of NAFLD is reported to be approximately 25% worldwide4,...
By now, non-alcoholic fatty liver disease (NAFLD) is considered to be among the most common liver diseases world-wide. NAFLD encompasses a broad spectrum of pathological conditions ranging from simple steatosis to steatohepatitis, fibrosis and finally even cirrhosis; however, only a minority of pati...